Publication Name	World Journal of Experimental Medicine
Manuscript ID	17668
Country	United Kingdom

Received	2015-03-18 09:29
Peer-Review Started	2015-03-18 20:26
To Make the First Decision	2015-04-10 17:29
Return for Revision	2015-04-15 13:31
Revised	2015-04-21 22:20
Second Decision	2015-04-30 16:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-05-08 16:31
Articles in Press	2015-05-08 16:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-13 14:30
Publish the Manuscript Online	2015-08-26 08:36

ISSN	2220-315x (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Editorial
Article Title	Interferon-γ: Promising therapeutic target in atherosclerosis
Manuscript Source	Invited Manuscript
All Author List	Joe WE Moss and Dipak P Ramji
Funding Agency and Grant Number
Corresponding Author	Dr. Dipak P Ramji, Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff CF10 3AX, United Kingdom. ramji@Cardiff.ac.uk
Key Words	Atherosclerosis; Interferon-γ; Inflammation; Neutralization; MicroRNA
Core Tip	Atherosclerosis is an inflammatory disorder of the vasculature and studies in mouse model systems have highlighted the beneficial effects of counteracting inflammation in limiting the progression of this disease. Due to its key role in inflammation and atherosclerosis development, interferon-γ (IFN-γ) is seen as a promising therapeutic target. In this editorial we discuss the role of IFN-γ in atherosclerosis together with potential therapeutic approaches against this cytokine and its key downstream targets.
Publish Date	2015-08-26 08:36
Citation	Moss JWE, Ramji DP. Interferon-γ: Promising therapeutic target in atherosclerosis. World J Exp Med 2015; 5(3): 154-159
URL	http://www.wjgnet.com/2220-315X/full/v5/i3/154.htm
DOI	http://dx.doi.org/10.5493/wjem.v5.i3.154

Full Article (PDF)	WJEM-5-154.pdf
Full Article (Word)	WJEM-5-154.doc
Manuscript File	17668-Review.docx
Answering Reviewers	17668-Answering reviewers.pdf
Audio Core Tip	17668-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17668-Conflict-of-interest statement.pdf
Copyright License Agreement	17668-Copyright assignment.pdf
Peer-review Report	17668-Peer-review(s).pdf
Scientific Misconduct Check	17668-Scientific misconduct check.pdf
Scientific Editor Work List	17668-Scientific editor work list.pdf